INTERNS 2026-I at Abbott

Bogota, D.C., Bogota, D.C., Colombia

Abbott Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Tener aval de la Universidad para realizar práctica profesional para el primer semestre del 2026 (inicio en diciembre 2025 - enero 2026)
  • Estudiantes universitarios en Bogotá que inician su práctica profesional en el semestre 2026-I
  • Posibilidad de hacer la práctica tiempo completo, Lunes a Viernes, durante 6 meses o 1 año (deseado)
  • Manejo de paquete Office (Word, PP, Excel) intermedio/avanzado
  • Nivel de inglés intermedio/avanzado

Responsibilities

  • Ser miembro activo del equipo de trabajo
  • Asumir tareas y responsabilidades retadoras para el desarrollo profesional
  • Entender desde el día a día cómo es el mundo laboral en la industria farmacéutica
  • Participar en proyectos y actividades propios del área asignada (e.g., Marketing, Finanzas, Comercial, etc.)
  • Participar en actividades que Abbott realiza anualmente especialmente para practicantes alrededor del mundo

Skills

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters
1888Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.
Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.
Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.
Abbott's microfluidic devices streamline diagnostic processes efficiently.
Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.
Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.
Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI